Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)
National Institutes of Health (NIH)
Total funding amount is up to $2.925 million in direct costs per year.
Maximum project period is 5 years.
To establish or renew Alzheimer's Disease Research Centers (ADRCs) that serve as national resources for research on Alzheimer's disease and related dementias.
To translate research advances into improved diagnosis, care, and treatment.
Major medical institutions across the United States.
Researchers in the field of Alzheimer's disease and related dementias.
Patients and families affected by Alzheimer's disease.
Eligible organizations include higher education institutions, public/state controlled institutions, private institutions, nonprofits, for-profit organizations, local/state/county governments, and tribal governments.
Non-domestic (non-U.S.) entities are not eligible to apply.
Applications are accepted from institutions located in the United States.
Non-domestic components of U.S. organizations are not eligible.
Projects must focus on Alzheimer's disease and related dementias.
Centers must provide a multidisciplinary approach to research and share resources.
Applications may request a budget of up to $2.925 million in direct costs per year.
No cost-sharing is required.
Application due date is September 26, 2025.
Only one application per institution is allowed.
The NIH will not accept duplicate or highly overlapping applications under review at the same time.
Applications must follow the Multi-Project (M) Instructions in the SF424 (R&R) Application Guide.
Applications will be evaluated based on significance, investigator qualifications, innovation, approach, and environment.
Applications are due by 5:00 PM local time of the applicant organization.
No late applications will be accepted.
Applications will be prioritized based on their potential to advance research on Alzheimer's disease and related dementias.
Centers must agree to collect and transmit a standard clinical data set to the National Alzheimer’s Coordinating Center (NACC).
Non-domestic components of U.S. organizations are not eligible to apply.
Collaboration with other NIH-funded programs is encouraged.
Strong institutional commitment and interdisciplinary collaboration are critical for success.
Demonstrated leadership in Alzheimer's disease research.
Strong institutional support and collaboration.
Submitting overlapping applications.
Engage with community partners to enhance recruitment and retention of participants.
Highlight unique resources and expertise in the application.